SCHEMBL31509503

SCHEMBL31509503

CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ NTSR2 O95665 15/20 0.66
▸ NTSR1 P30989 15/20 0.66
▸ SORT1 Q99523 13/20 0.66
▸ SLC6A2 P23975 1/20 0.60
▸ REN P00797 1/20 0.57
▸ AGTR1 P30556 1/20 0.56
▸ AGTR2 P50052 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30898606 0.89 NTSR1 (0.58) NTSR2NTSR1SORT1REN
SCHEMBL29533517 0.87 NTSR1 (0.82) NTSR2NTSR1SORT1
SCHEMBL30385275 0.87 NTSR1 (0.64) NTSR2NTSR1SORT1
SCHEMBL29655338 0.86 NTSR2 (0.62) NTSR2NTSR1SORT1SLC6A2
SCHEMBL31406966 0.86 SLC6A2 (0.72) NTSR2NTSR1SORT1SLC6A2REN
SCHEMBL31411493 0.86 NTSR1 (0.62) NTSR2NTSR1SORT1SLC6A2REN
SCHEMBL31634123 0.85 NTSR2 (0.60) NTSR2NTSR1SORT1
SCHEMBL30880437 0.85 NTSR1 (0.82) NTSR2NTSR1SORT1
SCHEMBL31509501 0.85 NTSR1 (0.61) NTSR2NTSR1SORT1SLC6A2REN
SCHEMBL31280899 0.85 NTSR1 (0.74) NTSR2NTSR1SORT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250213646-A1 BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TREATING SKIN L'OREAL (FR) 2025-07-03 — — US claimed
WO-2025096719-A1 BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN L'OREAL (FR) 2025-05-08 — — WO claimed
US-20250134794-A1 BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN L'OREAL (FR) 2025-05-01 — — US claimed
US-20260060913-A1 BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS L'OREAL (FR) 2026-03-05 — — US disclosed
US-20250213646-A1 BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TREATING SKIN L'OREAL (FR) 2025-07-03 — — US disclosed
WO-2025096719-A1 BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN L'OREAL (FR) 2025-05-08 — — WO disclosed
US-20250134794-A1 BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN L'OREAL (FR) 2025-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060913-A1 BIOACTIVE WALNUT PEPTIDES FOR TREATING HAIR LOSS TYR, CUTA, ARGLU1 NTSR2 1629/4885NTSR1 1686/4885SORT1 1196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback